-DOCSTART- -X- O
Infectious -X- _ B-Patient
diseases -X- _ I-Patient
represent -X- _ O
a -X- _ O
continuous -X- _ O
and -X- _ O
increasing -X- _ O
threat -X- _ O
to -X- _ O
human -X- _ O
health -X- _ O
and -X- _ O
welfare. -X- _ O
Due -X- _ O
to -X- _ O
emerging -X- _ O
diseases -X- _ O
, -X- _ O
increasing -X- _ O
resistances -X- _ O
, -X- _ O
international -X- _ O
travelling -X- _ O
, -X- _ O
and -X- _ O
the -X- _ O
risk -X- _ O
of -X- _ O
bioterroristic -X- _ O
attacks -X- _ O
, -X- _ O
infectious -X- _ B-Patient
diseases -X- _ I-Patient
concern -X- _ O
the -X- _ O
whole -X- _ O
world -X- _ O
and -X- _ O
can -X- _ O
only -X- _ O
be -X- _ O
combated -X- _ O
by -X- _ O
internationally -X- _ O
coordinated -X- _ O
and -X- _ O
interdisciplinary -X- _ O
approaches. -X- _ O
When -X- _ O
assessing -X- _ O
the -X- _ O
worldwide -X- _ O
publication -X- _ O
activities -X- _ O
on -X- _ O
infectious -X- _ O
diseases -X- _ O
in -X- _ O
the -X- _ O
years -X- _ O
1994–2004 -X- _ O
accessible -X- _ O
via -X- _ O
the -X- _ O
ISI -X- _ O
Science -X- _ O
Citation -X- _ O
Index -X- _ O
Expanded -X- _ O
( -X- _ O
® -X- _ O
) -X- _ O
, -X- _ O
an -X- _ B-Outcome
overall -X- _ I-Outcome
increase -X- _ I-Outcome
by -X- _ I-Outcome
24 -X- _ I-Outcome
% -X- _ I-Outcome
can -X- _ I-Outcome
be -X- _ I-Outcome
monitored. -X- _ I-Outcome
Furthermore -X- _ O
, -X- _ O
it -X- _ O
becomes -X- _ O
evident -X- _ O
that -X- _ O
highest -X- _ B-Outcome
research -X- _ I-Outcome
priorities -X- _ I-Outcome
are -X- _ I-Outcome
given -X- _ I-Outcome
to -X- _ I-Outcome
HIV -X- _ I-Outcome
/ -X- _ I-Outcome
AIDS -X- _ I-Outcome
, -X- _ I-Outcome
hepatitis -X- _ I-Outcome
C -X- _ I-Outcome
, -X- _ I-Outcome
tuberculosis -X- _ I-Outcome
, -X- _ I-Outcome
respiratory -X- _ I-Outcome
infections -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
sepsis. -X- _ I-Outcome
Ten -X- _ O
countries -X- _ O
– -X- _ O
including -X- _ O
the -X- _ O
USA -X- _ O
, -X- _ O
the -X- _ O
UK -X- _ O
, -X- _ O
France -X- _ O
, -X- _ O
Germany -X- _ O
, -X- _ O
and -X- _ O
Japan -X- _ O
– -X- _ O
contributed -X- _ O
to -X- _ O
more -X- _ O
than -X- _ O
80 -X- _ O
% -X- _ O
of -X- _ O
these -X- _ O
publications -X- _ O
; -X- _ O
nation-specific -X- _ O
research -X- _ O
priorities -X- _ O
focusing -X- _ O
on -X- _ O
the -X- _ O
current -X- _ O
problems -X- _ O
in -X- _ O
the -X- _ O
respective -X- _ O
country -X- _ O
can -X- _ O
be -X- _ O
estimated. -X- _ O
Countries -X- _ O
with -X- _ O
the -X- _ O
highest -X- _ O
disease -X- _ O
burdens -X- _ O
are -X- _ O
still -X- _ O
not -X- _ O
given -X- _ O
the -X- _ O
opportunity -X- _ O
to -X- _ O
contribute -X- _ O
adequately -X- _ O
to -X- _ O
the -X- _ O
scientific -X- _ O
field. -X- _ O
Based -X- _ O
on -X- _ O
our -X- _ O
data -X- _ O
, -X- _ O
relatively -X- _ B-Outcome
increasing -X- _ I-Outcome
publication -X- _ I-Outcome
activities -X- _ I-Outcome
include -X- _ I-Outcome
those -X- _ I-Outcome
on -X- _ I-Outcome
respiratory -X- _ I-Outcome
infections -X- _ I-Outcome
, -X- _ I-Outcome
tuberculosis -X- _ I-Outcome
, -X- _ I-Outcome
malaria -X- _ I-Outcome
, -X- _ I-Outcome
hepatitis -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
sepsis -X- _ I-Outcome
, -X- _ I-Outcome
whereas -X- _ I-Outcome
decreasing -X- _ I-Outcome
activities -X- _ I-Outcome
were -X- _ I-Outcome
determined -X- _ I-Outcome
for -X- _ I-Outcome
AIDS -X- _ I-Outcome
, -X- _ I-Outcome
diarrhoea -X- _ I-Outcome
, -X- _ I-Outcome
meningitis -X- _ I-Outcome
, -X- _ I-Outcome
schistosomiasis -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
other -X- _ I-Outcome
diseases. -X- _ I-Outcome
Accordingly -X- _ O
, -X- _ O
the -X- _ O
prevalence -X- _ O
of -X- _ O
many -X- _ O
infectious -X- _ O
diseases -X- _ O
occurring -X- _ O
in -X- _ O
tropical -X- _ O
countries -X- _ O
is -X- _ O
not -X- _ O
clearly -X- _ O
reflected -X- _ O
in -X- _ O
the -X- _ O
worldwide -X- _ O
publication -X- _ O
activities -X- _ O
. -X- _ O

